Regeneron Pharmaceuticals
Last quote: (Paris time)
Source: Yahoo FinanceDelayed quotesOutdated data
Synthèse : Regeneron Pharmaceuticals
Regeneron Pharmaceuticals (REGN) est cotée sur Nasdaq (United States), dans le secteur Health. Son cours est exprimé en USD. TimeLinq suit 119 autres valeurs du secteur Health, avec lesquelles cette fiche permet de la comparer.
Sa capitalisation boursière atteint 81.41B $. Son PER sur les 12 derniers mois est de 19.6. Sa marge nette ressort à 27.9%. Son rendement du dividende est de 0.48%.
Sur un an, le cours a varié de +37.1%, avec une volatilité annuelle de 33%. Le cours se situe au-dessus de sa moyenne mobile à 200 jours (+7.5%).
Indications calculated automatically from public market data; they do not constitute investment advice.
Price change
Regeneron Pharmaceuticals : de 789.45 $ à 790.74 $ over 1 month, soit une variation de +0.16%.
Source: Yahoo FinanceDelayed quotes, Paris timeOutdated data
Key figures
- Previous close
- $796.34
- Day's range
- $787.33 – $805.68
- Volume (shares)
- 653,505
- Listing venue
- Nasdaq
- 52-Week Range
- $572.75$859.34
Source: Yahoo FinanceOutdated data
In brief
The key figures, explained simply.
- 1-year performance
- +37.1%Change in share price over the past 12 months.
- Market capitalization
- 81.41B $Total market value of the company.
- P/E (12M)
- 19.6How many years of current earnings the share price represents.
- Net margin
- 27.9%Out of every 100 in sales, what remains as profit.
- Volatility (1 year)
- 33%Typical magnitude of share price moves over one year.
- Dividend yield
- 0.48%Annual dividend relative to the share price.
Fundamental modelThe share price is below the range of our valuation models ($791.65 – $887.77). See the Valuation tab for assumptions.
Source: Yahoo Finance (données fondamentales)Published accounts, indicative data
Company profile
- Sector
- Health
- Listing venue
- Nasdaq
- Region
- United States
- Quote currency
- USD
Other companies in the Health sector
Click a company to open its profile, or compare it directly.
| Company | Price | Change | Market capitalization | P/E | Compare |
|---|---|---|---|---|---|
| Eli LillyLLY | $1,257.03 | +0.43% | 1.12T $ | 42.2 | Compare |
| Johnson & JohnsonJNJ | $255.56 | +0.90% | 615.87B $ | 38.8 | Compare |
| UnitedHealthUNH | $401.43 | −1.29% | 360.32B $ | 25.8 | Compare |
| Merck & Co.MRK | $145.95 | +0.52% | 360.08B $ | 115.8 | Compare |
| PfizerPFE | $29.58 | +0.48% | 168.6B $ | 38.9 | Compare |
| AbbVieABBV | $285.42 | +0.71% | 504.37B $ | 80.6 | Compare |
| Abbott LaboratoriesABT | $104.89 | +0.20% | 182.7B $ | 33.8 | Compare |
| Thermo Fisher ScientificTMO | $690.00 | −0.93% | 255.13B $ | 37.1 | Compare |
| Agilent TechnologiesA | $172.97 | −1.47% | 48.77B $ | 34.1 | Compare |
| Align TechnologyALGN | $147.31 | −1.36% | 10.46B $ | 25.6 | Compare |
Source: Yahoo FinanceDelayed quotes